After Recent Run, Penumbra Downgraded On Fears Its Upside Is Exhausted

By: via Benzinga
The medical device company Penumbra Inc (NYSE: PEN) issued a consensus-beating earnings report Nov. 7. The Analyst BMO ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.